首页> 外文期刊>British Journal of Pharmacology >Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes
【24h】

Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes

机译:使用大鼠肝脏灌注液和微粒体评估疟疾感染对双氢青蒿素肝清除率的影响

获取原文
获取原文并翻译 | 示例
       

摘要

The clearance of dihydroartemisinin(DHA) in control and malaria-infected(MI) rats was investigated using the isolated perfused rat liver(IPRL) model and hepatic microsomal studies. In the recirculating IRPL, clearance of DHA was reduced from a mean (s.d.) of 8.2±1.8 ml min~-1 in Controls(n =8) to 6.0±1.0 ml min~-1 in MI(n=8; P<0.01). clearance in control livers was similar to The perfusion flow rate, suggesting a high hepatic extraction ratio of DHA. Single-pass IPRL studies in controls (n =8) showed that DHA bioavailability at 1.3, 8 and 38μM was 0.026±0.020, 0.043±0.025 and 0.14±0.06, respectively (P <0.001 for 8 μM vs 38μm).
机译:使用离体灌流大鼠肝脏(IPRL)模型和肝微粒体研究,研究了对照和疟疾感染(MI)大鼠中双氢青蒿素(DHA)的清除率。在再循环IRPL中,DHA的清除率从对照组(n = 8)的平均值(sd)8.2±1.8 ml min〜-1降低到MI组的6.0±1.0 ml min〜-1(n = 8; P < 0.01)。对照肝的清除率与灌注流速相似,表明DHA的肝提取率较高。对照组(n = 8)的单次IPRL研究表明,在1.3、8和38μM时DHA的生物利用度分别为0.026±0.020、0.043±0.025和0.14±0.06(8μM对38μm的P <0.001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号